Track the 에이프로젠바이오로직스 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 에이프로젠바이오로직스 has published 91 public disclosures. The latest transaction was filed on 7 July 2026 (Purchase). Among the most active insiders: 에이프로젠. Every trade is openly available.
82
Insider Decl.
n/a
Thresholds
n/a
48 ops.
Buy Volume
n/a
16 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.